miércoles, 10 de diciembre de 2014

STATISTICAL BRIEF #442: Changes in Osteoporosis Medication Use and Expenditures among Women (Age ≥ 50), United States, 2000 to 2011

FULL-TEXT ►

STATISTICAL BRIEF #442: Changes in Osteoporosis Medication Use and Expenditures among Women (Age ≥ 50), United States, 2000 to 2011



AHRQ Electronic Newsletter - Agency for Healthcare Research and Quality



AHRQ Stats: Osteoporosis Treatments

Among U.S. women age 50 and older, the percentage using selective estrogen receptor modulators dropped from 4 percent in 2000-2001 to less than 2 percent in 2010-2011, while the use of bisphosphonates increased from 6 percent to 8 percent during the same time period. (Source: Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey Statistical Brief #442: Changes in Osteoporosis Medication Use and Expenditures among Women (Age 50 and up), United States, 2000 to 2011.)

STATISTICAL BRIEF #442:
Changes in Osteoporosis Medication Use and Expenditures among Women (Age ≥ 50), United States, 2000 to 2011


June 2014
Eric M. Sarpong, PhD

Highlights

  • Between 2000–2001 and 2010–2011, average annual percent of women (age ≥ 50) who reported using any selective estrogen receptor modulators (SERMs) decreased from 4.1 to 1.6 percent. However, the average annual percentage who reported using any bisphosphonates increased from 5.6 percent in 2000–2001 to 8.3 percent in 2010–2011.
  • Among women (age ≥ 50), average annual expenditures on SERMs decreased from $30 in 2000–2001 to $14 in 2010–2011. Average annual expenditures on bisphosphonates increased from $30 in 2000–2001 to $41 in 2010–2011.
  • Among women (age ≥ 50), annual expenditures per user on SERMs and bisphosphonates averaged $669 and $500 in 2000–2001, and $771 and $450 in 2010–2011.

No hay comentarios: